ArticleCureus2025
Recalcitrant Palmar Warts Treated With Q-Switched Potassium Titanyl Phosphate Laser and Cryotherapy: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recalcitrant palmar common warts pose a considerable challenge in dermatology due to their frequent persistence despite various treatment attempts. The thick stratum corneum of the palms and the constant pressure and friction in this location contribute to their resistance to therapy and a high rate of recurrence. We report the case of a 33-year-old male with a 26-month history of a progressively enlarging palmar wart refractory to extensive conventional therapies, including 18 intermittent sessions of liquid nitrogen cryotherapy administered over the course of his 26-month history, two electrofulguration sessions, and various topical agents. We applied a novel multimodal treatment involving superficial shaving, followed by Q-switched potassium titanyl phosphate laser at 12 J/cm² fluence, combined with cryotherapy using liquid nitrogen. After two sessions, administered two weeks apart, complete clinical and dermatoscopic resolution was achieved within two weeks of the final treatment. No recurrence was observed at a three-month follow-up. The patient experienced minimal adverse effects, with mild and transient discomfort and erythema, but no vesiculation, blistering, or pain. Our literature search revealed no previously reported cases of recalcitrant palmar verruca vulgaris successfully treated with Q-switched potassium titanyl phosphate laser using this multimodal protocol. This case highlights a promising and previously undescribed combined strategy for managing highly refractory palmar warts unresponsive to standard treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.